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Objective: The primary aim of the Berkeley Contact Lens Extended Wear Study (CLEWS) was to test the
hypotheses that extended wear of rigid gas-permeable (RGP) contact lenses with greater oxygen permeability
(Dk) reduces the incidence of contact lens–associated keratopathy (CLAK) and increases the survival rate in RGP
extended wear (EW). In this article we describe the clinical trial design in detail, present the results of subject
recruitment and retention, and provide the baseline demographic and ocular characteristics of the CLEWS
subjects, whose data will be analyzed to address the study aims in a companion article.
Design: A randomized, concurrently controlled clinical trial.
Intervention: Subjects were fitted with day wear (DW) high-Dk RGP lenses and then adapted to EW.
Subjects who adapted to EW were then randomly assigned to either high- or medium-Dk RGP lenses for 12
months of 6-nights/week EW.
Main Outcome Measures: Slit-lamp assessment and grading of 17 possible keratopathies, measurement
of refractive error and corneal curvature, and symptoms. Follow-up data were collected every 3 months.
Results: From 545 subjects entering the DW adaptation phase, 201 adapted to EW and were randomly
assigned to medium- or high-Dk lenses for 12 months of EW. The baseline characteristics of the two study
groups were similar and did not differ from the 344 DW subjects who failed to adapt to EW. The distributions of
oxygen transmissibility for the two study groups were disjoint, indicating that each group received distinctly
different levels of hypoxia.
Conclusions: We show that CLEWS was appropriately designed to address the study hypotheses, was
conducted with regard for the safety of the subjects, and adhered to rigorous protocols designed to control for
bias and ensure the integrity of study data. We establish the internal validity of between-group statistical
comparisons and characterize our study population to permit informed evaluation of the applicability of our
results to the contact lens–wearing population in general. Ophthalmology 2001;108:1381–1388 © 2001 by the
American Academy of Ophthalmology.
Contact lens (CL) extended wear has been associated with
the development of various corneal complications, some of
which can cause permanent visual impairment.1–5 Concerns
about the risks associated with CL wear have resulted in
considerable research aimed at ameliorating CL-associated
keratopathy. Several studies have shown an association
between wearing lenses known to cause corneal hypoxia
and the occurrence of adverse corneal events such as in-
creased epithelial cell loss,4 inflammation,5 microbial kera-
titis,1,2 acute red eye,4 and endothelial polymegethism.6
Under controlled laboratory testing conditions, decreased
lens oxygen transmissibility (Dk/t) has been associated with
increased corneal swelling,7,8 increased binding of Pseudo-
monas aeruginosa to epithelial cells (Cavanagh HD, Ren H,
Ladage PM, et al. Invest Ophthalmol Vis Sci 40:S906,
1999), decreased desquamation rates of epithelial cells,9
impaired corneal volume regulation,10 and lowered corneal
pH.11
On the basis of these findings, many clinicians and
researchers have assumed that the incidence and severity of
CL-related adverse events depend in part on the hypoxic
dosage (i.e., oxygen tension at the tear-lens interface) that
the cornea receives during overnight lens wear. Although
these studies provide evidence for a hypoxic mechanism,
further research is required to clearly demonstrate a link
between hypoxic dosage and either the incidence of com-
plications or the ability to maintain successful CL extended
wear. Determining whether there is a dose-response rela-
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tionship between the risk of keratopathy and corneal hyp-
oxia, or whether, for example, the risk is uniformly in-
creased given some threshold hypoxic level, has
implications for understanding the mechanisms associated
with CL-associated keratopathy, as well as for the design
and clinical use of CLs.
This uncertainty about the exact relationship between
hypoxia and adverse ocular response in overnight CL wear
prompted our corneal research group to undertake the
Berkeley Contact Lens Extended Wear Study (CLEWS).
CLEWS was a randomized, concurrently controlled clinical
trial involving comprehensive quarterly follow-up of more
than 200 subjects randomly assigned to wear either medi-
um- or high-oxygen permeable (Dk) rigid gas-permeable
(RGP) lenses for 12 months of extended wear (EW). The
primary aims of CLEWS were to determine whether wear-
ing high oxygen-permeable RGP lenses for extended wear
(1) lowers the incidence of CL-associated keratopathy, and
(2) reduces the rate at which subjects discontinue overnight
wear because of lens-related complications. Secondary aims
of the study were to assess the effects of hypoxic dosage on
various laboratory measures of corneal structure and func-
tion, to identify possible predictors of RGP EW–associated
keratopathy, and to develop a semiautomated data manage-
ment and quality assurance system for clinical research.
CLEWS lasted for approximately 5 years, from the begin-
ning of recruitment in April 1994 to the end of data collec-
tion in July 1999.
The purposes of this first article are to (1) present the
main features of the CLEWS clinical trial design; (2) de-
scribe the recruitment, measurement, and bias control strat-
egies; and (3) present the results of subject recruitment,
retention, and baseline assessments, which are necessary to
define the CLEWS study population and permit interpreta-
tion of subsequent statistical results. We analyze in a com-
panion article (Polse KA, Graham AD, Fusaro RE, et al,
The Berkeley Contact Lens Extended Wear Study. Part II:
Clinical Results) the clinical outcomes to address the pri-
mary study aims. Secondary aims of CLEWS will be ad-
dressed in several other separate articles.
Material and Methods
CLEWS was designed with three main stages: screening and
baseline evaluation (stage 1), adaptation to CL wear (stage 2), and
randomized lens wear and follow-up (stage 3). We first describe
these three stages in detail, outline the bias control measures used
in CLEWS, and describe the changes in protocol made during the
course of the trial. We then describe the study lenses, personnel,
and procedures, including data management and quality assurance
and external interim review of CLEWS conduct by a Data and
Safety Monitoring Board (DSMB).
The CLEWS Clinical Trial Design
Stage 1. Screening and Baseline Evaluation
Prospective subjects were recruited from the San Francisco Bay
Area and the general University of California at Berkeley
(UCB) community through newspaper advertisements, fliers,
UCB School of Optometry clinic referrals, and direct referrals.
All subjects attended an orientation meeting at which informa-
tion about age, gender, ethnicity, occupation, medical history,
and previous CL experience was collected, the current spectacle
prescription measured, and keratometry readings obtained. Ta-
ble 1 lists the eligibility criteria used in stage 1 to accept or
reject prospective subjects.
Because some types of CL wear have been shown to affect
corneal structure and function,10,12 we initially attempted to enroll
only subjects with no previous CL experience; however, unantic-
ipated difficulties in enrolling eligible subjects for full participa-
tion in CLEWS prompted us to accept subjects with some minimal
CL experience (as defined in Table 1). No prior polymethyl-
methacrylate or overnight CL wear was permitted. Day wear of
RGP or soft lenses was permitted if the subject had worn CLs for
less than 6 months total wearing time. For subjects with longer
total time in CL wear, a set of rules was applied that accounted for
how recently and how many hours per week, on average, lenses
were worn. We believe these criteria reflected minimal CL expe-
rience that was unlikely to have had a negative impact on the
cornea before participation in CLEWS.
Subjects who met the initial screening criteria were then given
a detailed explanation of the study procedures, followed by a
comprehensive eye and CL fitting examination. Those subjects
meeting all study eligibility criteria then proceeded to stage 2.
Informed consent, as approved by the UCB Committee for Pro-
tection of Human Subjects, was obtained from each participant.
Stage 2. Adaptation to Contact Lens Wear
In stage 2, subjects adapted first to day wear of high-Dk RGP
lenses and, if successful, then proceeded to EW adaptation, fol-
lowing standard clinical procedures.13 All subjects wore the
high-Dk lenses throughout stage 2 to avoid any bias that could
arise if subjects were to begin adaptation with their assigned study
lenses (i.e., medium- or high-Dk) and then experienced differing
group success rates in adaptation. Beginning with 4 hours on the
first day, wearing time was increased by 2 hours/day until 8
Table 1. Contact Lens Extended Wear Study Eligibility Criteria
at Date of Initial Orientation. (Subjects Who Met These
Screening Criteria Were Then Scheduled for a Clinical
Examination and Diagnostic Lens Fitting to Determine Final
Eligibility to Participate in Contact Lens Extended Wear Study
and to Enter the Lens Wear Adaptation Phase [Stage 2]).
1. Age: 18 to 39
2. Ocular health: normal
3. Refractive error: 17.00 to 29.00 diopter spherical, and 0.00 to
21.75 diopter cylindric
4. Residence: San Francisco Bay Area for at least the next 1.5 yrs
5. Ocular or medical history: no conditions or injuries that might
adversely affect ocular health or otherwise limit ability to wear
contact lenses
c Corneal surgery, corneal trauma
c Medications, including antidepressants, steroids
c Allergies with pronounced ocular effects (e.g., tearing, itching)
6. History of overnight polymethyl methacrylate contact lens wear:
none
7. History of or current daily contact lens wear: minimal or none
c , 6 months total wearing time, or
c Currently wearing, or discontinued # 6 mos ago
Worn # 12 mos, , 30 hs/wk average
Worn . 12 mos, , 15 hs/wk average
c Discontinued wear . 6 mos ago
Worn # 24 mos, , 30 hs/wk average
Worn . 24 mos, , 15 hs/wk average
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hours/day was reached. At approximately 1-week intervals there-
after, subjects reported for follow-up examinations that included
history, visual acuity, lens assessment, keratometry, and slit-lamp
assessment. Lens changes were made when indicated to help the
patient achieve full-time day wear (14–16 hours/day). Additional
information on the day wear adaptation phase of this trial has been
reported elsewhere.14
On successful adaptation to full-time day wear, the subjects
attempted overnight wear and reported in the morning after the
first and fourth nights for clinical evaluations. If the subjects had
no difficulty with overnight wear (e.g., no discomfort, no red eye)
and the clinical assessments revealed no complications, a 1-week
regimen of full-time EW was prescribed consisting of 6 nights of
lens wear and 1 night without lens wear. If this EW schedule could
be maintained without complications for 4 weeks, the subjects
were considered “adapted” and proceeded to stage 3. Subgroups of
CLEWS subjects were also asked to participate in a variety of
laboratory assessments, including endothelial photomicroscopy
and measurements of corneal hydration control, overnight corneal
swelling, and epithelial permeability. Baseline laboratory data
were taken on participating subjects during stage 2.
Stage 3. Randomized Lens Wear and Follow-up
Subjects entering stage 3 were randomly assigned to either a high-
or medium-Dk lens group for 12 months of EW. Clinical assess-
ment examinations were scheduled after randomization at 3, 6, 9,
and 12 months. These examinations included an oral history, lens
assessment, keratometry, manifest refraction, and a detailed slit-
lamp examination. The slit-lamp examination included inspection
of lids, conjunctiva, and cornea, with each of these areas further
subdivided (e.g., bulbar and palpebral conjunctiva, central and
peripheral cornea) for grading by clinicians of 17 possible ocular
conditions (e.g., corneal staining, hyperemia, microcysts, infil-
trates). Each subdivided area was graded on a 0 to 3 scale (0 5
none, 1 5 mild, 2 5 moderate, and 3 5 severe) according to the
Mandell Slit Lamp Classification Protocol.15 Subjects participat-
ing in overnight corneal swelling measurements also had pachom-
etry readings taken at 3-month intervals. Subjects who participated
in baseline (i.e., prerandomization) endothelial photomicroscopy
or corneal hydration control measurements had these procedures
repeated at the final 12-month visit. Laboratory results from these
subsets of CLEWS subjects will be reported in a separate article.
In addition to the regularly scheduled clinical visits of stage 3,
subjects could report for unscheduled visits because of onset of
adverse symptoms or at the request of the attending optometrist
(e.g., to monitor development of subclinical keratopathy observed
at a regular quarterly visit). During any phase of the study, subjects
could elect to discontinue participation or be dropped from the
study by decision of the clinician and principal investigator (PI).
At the conclusion of the study, subjects were asked to discontinue
lens wear for 1 week and report for a final clinical assessment.
Bias Control Measures
Randomization
We assigned subjects to the medium- or high-Dk lens groups by
means of a stratified block-randomization scheme. Because age
and gender were likely to be associated with outcomes, we used
stratified randomization to balance these subject features across the
study lens groups. That is, within strata defined by age (#30, .30
years) and gender, subjects were assigned to one of the two study
lens groups using a randomized block scheme with assignments
based on randomly permuted block sizes of two or four subjects.
Block randomization ensured that, at most, four consecutive sub-
jects within a stratum could be assigned to the same lens group.
Permuting the block sizes (either two or four) ensured that study
personnel who were also involved in recruitment activities re-
mained masked as to future randomizations in that stratum. Over-
all, this randomization strategy ensured balanced allocation of
subjects to the two lens groups throughout the course of the trial,
thus protecting against possible biases in group comparisons re-
sulting from temporal changes (e.g., altered eligibility criteria,
personnel changes, instrument drift, procedural changes, observer
criteria changes over time). To implement this scheme, we gener-
ated the randomized block assignments for each stratum using
random number generating functions in SPlus (MathSoft, Inc.,
Seattle, WA).16 These lists were then stored in SAS (SAS Institute,
Inc., Cary, NC)17 database tables and accessed by study personnel
through an SAS application that included real-time verification of
the subject’s name, age, gender, and study identification number,
ensured that the subject had complete stage 1 and 2 data entered on
the study database, and verified that the subject had not already
been assigned to a study lens group.
Masking
The PI, optometrists, and technicians were masked to the lens
assignment of all patients at all times, as were the patients them-
selves, which was possible because the two study lenses were
indistinguishable by visual inspection. The study coordinator re-
quired access to this information to place the lens orders but did
not participate in subject examinations or data collection. The
biostatistician also had access to this information but retained it in
a separate data table that was rarely examined during the trial and
was not aware of lens group assignments when making specific
decisions about recruitment, retention, or data error resolution.
Laboratory measurements were performed by technicians who
were not aware of randomization assignments, and optometrists
did not have access to laboratory data and referred to prior clinical
examination records only when necessary for patient safety. Ex-
cept in rare cases, each subject was seen by the same optometrist
and technician for each examination throughout the study to con-
trol for interobserver variation.
Changes in Protocol from Original Design
Shortly after the start of the study, it became apparent that protocol
changes were needed to improve subject recruitment and retention.
After the first 6 months of active recruitment, it was evident that
although an adequate number of subjects were attending orienta-
tion meetings, more subjects than expected were failing to reach
stage 3 randomization. To attract a greater number of potential
subjects and to improve subject retention in stages 1 and 2, we
implemented four changes in the study protocol: (1) reduction of
the proposed follow-up period from 3 years to 1 year; (2) relax-
ation of the requirement of no prior CL experience to permit some
limited history of CL wear; (3) elimination of the arduous corneal
hydration control measurements; and (4) reduction of the proposed
no-CL wear period at the end of the 12-month follow-up from 3
months to 1 week. These changes were implemented less than 8
months after the start of recruitment, at which point only 13
subjects had been randomly assigned and only 3 of those had
completed the first quarterly clinical assessment. These four
changes allowed us to recruit and retain a sufficient number of
subjects to complete the clinical trial with adequate statistical
power to address our primary aims and without substantially
altering the baseline demographic and ocular characteristics of our
subject group.
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Study Materials, Personnel,
and Procedural Review
Lens Materials and Fitting Strategy. RGP lenses were selected
for this study, because they are available in a range of oxygen
transmissibilities in designs identical in every other respect. The
medium- and high-Dk CLs used in this study (paflufocon B and
paflufocon D) were made from a Siloxane-fluorocarbon polymer
(Paragon Vision Sciences, Mesa, AZ), and both Dk materials have
been used extensively for clinical RGP lens wear. The mean Dk of
four randomly selected paflufocon B and paflufocon D lenses were
45 3 10211 and 92 3 10211 (cm2/sec)(ml O2/ml 3 mmHg),
respectively, which are approved by the Food and Drug Admin-
istration for EW. On average, these lenses were made with a
central thickness of 0.17 mm and varied from 0.12 to 0.22 mm in
both Dk groups, which gives a range of oxygen transmissibility
(Dk/t) of 21 to 38 and 43 to 77 (1029 [cm 3 ml 3 O2]/[sec 3
ml 3 mmHg]) for the paflufocon B and paflufocon D lenses,
respectively. The average overall lens diameter for both lens
materials was 9.2 mm. Lenses were fitted with a base curve radius
that was slightly longer than the flat corneal meridian as measured
by keratometry. For each 1.00 diopter of corneal toxicity (as
measured by keratometry), the base curve radius was increased
approximately 0.05 mm (i.e., 0.25 diopter). Secondary and periph-
eral curve radii were made to be 1.0 and 3.0 mm flatter that the
central base curve, with widths of 0.2 and 0.3 mm for the second-
ary and peripheral curves, respectively. Criteria for an acceptable
diagnostic fit included either lid attachment (i.e., lens riding
slightly under the upper lid after the blink) or interpalpebral fit. In
both cases we attempted to achieve optimal lens movement during
the interblink period that would allow the lens to gravitate 1 to 2
mm toward the inferior lid margin with a slow vertical movement.
An acceptable bearing relationship included an even distribution of
fluorescein under the lens and an adequate peripheral lens tear
reservoir (without excessive edge standoff).
Study Personnel. Both optometrists and optometric techni-
cians participated in taking study measurements. The optometrists
were CL specialists with considerable clinical experience in RGP
design, fitting, and follow-up care, who were responsible for
performing the initial eye examinations, CL fittings, epithelial
permeability measurements, and all clinical examinations during
the 12 months of EW. Optometric technicians were trained to
perform pachometry, endothelial photomicroscopy and digitizing,
lens verification, and subject training in CL handling procedures.
All technicians successfully completed a rigorous certification
process for each instrument and laboratory procedure and were
periodically retested to ensure that they maintained a consistently
high standard. In addition to the optometrists and technicians, the
research team included a faculty biostatistician who, as co-PI for
most of the CLEWS study, was instrumental in the design and
implementation of the trial including review by a DSMB and the
creation of data analysis strategies. A senior biostatistician was
responsible for monitoring of recruitment and retention, database
design and data management, and working with the faculty bio-
statistician and the PI in statistical analyses. A study coordinator
was responsible for patient scheduling, implementing recruitment
procedures (e.g., posting advertisements, contacting the clinic for
information on referrals), organizing and filing all patient records,
and some data entry and computer file management under the
supervision of the biostatistician.
External Interim Review. CLEWS received institutional ap-
proval from the University of California at Berkeley Committee
for Protection of Human Subjects. In addition, an independent
DSMB was appointed to conduct an interim review of CLEWS
with regard to safety and related issues. Members of the DSMB
consisted of (1) an infectious disease physician/epidemiologist, (2)
a biostatistician (chairperson), (3) a university-based optometrist
with expertise in CL fitting, (4) an ophthalmologist with expertise
in external disease, and (5) a community member. When approx-
imately 60% of the study was complete, the DSMB received
presentations concerning implementation of the study design, ef-
forts to protect human subjects, and preliminary data related to
safety. The DSMB concluded that the study was being conducted
in a manner consistent with providing optimal protection to the
subjects and that the study lenses had caused no adverse ocular
events of a severity to warrant discontinuation of the study. The
DSMB concluded that the alterations to the study design in re-
sponse to recruiting and retention problems were timely and oth-
erwise appropriate and that the study retained sufficient statistical
power to achieve its primary aims. The committee recommended
that the trial continue and that an additional meeting was not
necessary unless new safety issues arose.
Data Management and Quality Assurance
The number and variety of measurements and observations per-
formed under this study design generated a vast array of demo-
graphic, historical, clinical, and laboratory data. It was necessary
to develop a method of data entry and verification that would
permit their timely review for monitoring recruitment and reten-
tion rates and for assuring patient safety and high data quality. We
used the Teleform system (Cardiff Software, San Marcos, CA),18
which uses optical mark and character recognition for scanning
data entry forms, provides tools for immediate verification of
accuracy, and permits design of customized data entry forms that
the optometrists could easily complete without disrupting the flow
of the examination or rapport with the patient. The study coordi-
nator was responsible for scanning forms, verifying data, and
working with the clinicians and biostatisticians to resolve data
entry errors. Details of the form design, data validation, and
performance capabilities of the Teleform system have been re-
ported elsewhere.19
After scanning and verification, the data were subjected to an
extensive set of quality assurance (QA) programs written for the
SAS system. The CLEWS QA system consisted of three levels of
SAS programs: (1) within-form checks for missing data, valid data
ranges and types, and logical relationships among form variables;
(2) comparison of new batches of scanned data to the master
CLEWS database, checks for duplicate forms, logical relationships
between current and prior patient data, and errors in the sequence
of visit dates; and (3) screening of the master database for logical
inconsistencies between different variables across different visits.
All laboratory data were also subjected to customized SAS QA
programs.
The QA system generated reports that flagged discrepancies in
the database that could represent either data entry errors or real
changes in the condition of the patient requiring an investigation
by the PI or attending optometrists (e.g., large changes in visual
acuity). The QA reports were first screened by the biostatistician,
and any data entry errors were resolved by referring to the data
entry forms and, if necessary, consulting the study coordinator or
optometrist. Flagged items that were not simple data entry errors
could possibly indicate real changes in patient status and thus were
referred to the PI for investigation. Data entry errors were more
common by far than real changes, although we did occasionally
encounter large changes in corneal curvature (e.g., . 1.0 diopter)
or reductions in visual acuity (e.g., . 2 lines on the visual acuity
chart) that prompted optometrist review of the patient records and
scheduling of the patient for follow-up examinations. The QA
reports did not reveal any previously unidentified adverse events
severe enough to warrant discontinuation of a subject from the
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study. All CLEWS data, clinical records, laboratory readings, and
QA reports were backed up at the instrument or scanning site, and
multiple copies were stored outside the laboratory area. New data
were backed up frequently as forms were scanned, QA reports
completed, or instrument readings performed, whereas the master
database was backed up monthly.
Results
Subject Recruitment and Retention
Figure 1 depicts the flow of subjects through the three stages of the
trial from the beginning of recruitment to the end of data collection
and termination from the study. A total of 2218 subjects respond-
ing to recruitment efforts entered stage 1 by attending a CLEWS
orientation from April 1994 through December 1997. Of these
2218 prospective subjects, 977 met the initial eligibility criteria
and were scheduled for comprehensive eye and CL fitting exam-
inations. Of these 977 subjects, 545 subjects met all the require-
ments for CL wear and study eligibility and were dispensed
high-Dk RGP adaptation lenses for entry into stage 2. Figure 2
shows the percentages of subjects who failed in either stage 1 or
stage 2. Of the 2218 subjects who entered stage 1, a total of 1673
did not proceed to stage 2 (75%), the primary reasons being that
they failed to meet eligibility criteria (59% of failures) or ex-
pressed a lack of interest in participating in CLEWS after the study
requirements were fully explained (40%). Among the 545 who
Figure 1. At any stage of the Contact Lens Extended Wear Study, clinical trial subjects could elect to discontinue participation, be dropped by the
clinician, or successfully complete the stage and proceed to the next. Shown within each of the three stages are the number of subjects entering that stage,
the various examinations and measurements performed, the number of subjects failing to complete these visits, and the number successfully completing
all visits for that stage. The timeline at the bottom shows when data collection for each stage began and was completed over the course of the 5-year study.
(CHC 5 corneal hydration control assessments; Clin Examination 5 quarterly clinical follow-up examinations; Endo photos 5 endothelial photomi-
crographs; O/N Swell 5 overnight corneal swelling measurements.) DW 5 day wear; EW 5 extended wear.
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entered stage 2, 344 failed to reach stage 3 randomization (63%).
Of those 344 subjects 17% had CL-related responses that were
sufficiently important to discontinue lens wear (typically central
corneal staining or persistent lens adherence), whereas another
34% of withdrawals were subject-initiated, primarily because of
lens-associated discomfort. For the remaining subjects (49%) who
did not proceed to stage 3, approximately 13% were dropped by the
clinician because of noncompliance with the CL adaptation protocol,
whereas 36% were due to issues not related to CL wear, such as
moving out of the area, difficulty in maintaining a commitment to the
study visit schedule, or nonocular related health issues.
Application of Hypoxic Dosage
The two study groups were allocated lenses with substantially
different Dk. If all other lens parameters were kept constant, the
two groups would have received two different levels of hypoxia
corresponding to the different lens Dk. However, the amount of
oxygen reaching the cornea is determined by the oxygen transmis-
sibility (Dk/t), which is a function of both the permeability of the
material and the thickness of the lens. Because lens thickness
varies with vertex power and study lenses varied in power among
CLEWS subjects, there was a range of Dk/t values for subjects
within each Dk group. To verify that the medium- and high-Dk
groups were subject to distinctly different hypoxic doses (i.e.,
different levels of oxygen reaching the cornea, determined by the
Dk/t), we examined the distribution of Dk/t when lens thickness is
taken into account for each subject. The histogram of Dk/t shown
in Figure 3 reveals that, despite the variability within each Dk lens
group caused by the subject-specific lens thicknesses, the distri-
butions of oxygen transmissibility are completely disjoint between
the two groups. We therefore conclude that the study groups did
receive different hypoxic doses.
Internal and External Validity
Of the 201 subjects randomly assigned to study lenses, 103 sub-
jects received the medium-Dk lenses and 98 received the high-Dk
lenses. Table 2 lists the baseline (i.e., prefitting) characteristics of
the two study groups and shows that the randomization scheme
maintained balance between the two groups in age and gender.
There were no important differences between the lens groups in
mean age, gender or ethnic composition, proportion with prior CL
history, mean corneal curvature, refractive error, or visual acuity.
The close similarity of these groups in terms of their baseline
characteristics ensures the internal validity of between-lens group
comparisons (i.e., because the two groups are comparable with
respect to the characteristics listed in Table 2, any apparent dif-
ferences we observe between groups in study outcomes will not be
due to confounding by these variables).
It is also important to compare the baseline characteristics of
the 344 subjects failing stage 2 to those of the 201 subjects who
entered stage 3 and whose data will be used in subsequent analy-
ses, because differences between randomly assigned subjects and
the original pool of eligible subjects might limit the external
validity, or “generalizability,” of our statistical results. That is, if
the subjects who successfully adapted to RGP EW and entered
stage 3 had different demographic or ocular features from the
eligible candidates who were not able to adapt to EW, statistical
results obtained using this sample would not necessarily be appli-
cable to the general CLEWS study population as defined by the
entrance criteria, adaptation criteria, and recruitment scheme. Ta-
ble 3 shows the baseline characteristics of the 344 stage 2 failures
and the 201 stage 3 randomly assigned subjects. As expected from
the pool of potential subjects from the Berkeley campus and
surrounding community, the mean age of initial entrants was
roughly 23 years, approximately 85% of subjects were students
(not shown in Table 3), and Asian-Americans and Caucasians
accounted for approximately 75% of the ethnic makeup. Mean
visual acuity, male-to-female ratios, and proportions of subjects
with prior CL history were similar. Although there were very
modest differences in mean corneal curvature and refractive error,
such differences are insignificant clinically and within the usual
measurement accuracy for these instruments. These comparisons
show that the eligible candidates who were unable to complete EW
adaptation did not display any clinically important differences
Figure 2. During stage 1 of the Contact Lens Extended Wear Study trial, subjects could discontinue participation either because of discomfort at the initial
fitting or because of factors unrelated to contact lens (CL) wear (e.g., time commitment, moving residence out of the area), or study personnel determining
that an interested potential subject did not meet eligibility criteria (approximately 14% for prior CL wear). Subjects entering stage 2 could elect to
discontinue because of discomfort during adaptation to daily or overnight wear or for reasons unrelated to lens wear, whereas the clinician could drop a
subject because of lens-related complications (approximately 17%) or noncompliance with the study protocol.
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Figure 3. Although the two randomized study groups received lenses of different oxygen permeabilities (Dk), it was possible that the range of oxygen
transmissibilities (Dk/t) caused by differences in lens thickness within each group could result in overlap in the hypoxic doses that the two groups received.
The histogram shows that the distributions of Dk/t for the two groups were separated, confirming that distinctly different hypoxic doses were delivered
to the study groups.
Table 2. Baseline Characteristics of Subjects who met Contact
Lens Extended Wear Study Eligibility Criteria, Successfully
Adapted to Rigid Gas-Permeable Extended Wear, and Were
Randomly Assigned to Either the Medium- or High-Oxygen
Transmissibility Group. The Similarity of These Characteristics
in the Two Study Groups Ensures that Apparent Group
Differences in Outcomes Will Not Be the Result of
Confounding by These Variables
Medium-Oxygen
Permeability
(n 5 103)
High-Oxygen
Permeability
(n 5 98)
Subjects with contact lens history (%) 22.33 18.37
Gender (%)
Male 56.31 56.12
Female 43.69 43.88
Ethnicity (%)
African American 5.83 6.12
Asian American 41.75 40.82
Caucasian 39.81 34.69
Hispanic American 4.85 10.20
Native American 0.97 1.02
Other 6.80 7.14
Mean age at orientation (years) 22.93 23.26
Mean corneal curvature (diopters)
Horizontal meridian 43.41 43.55
Vertical meridian 44.12 44.18
Toricity 0.79 0.74
Residual astigmatism 1.27 1.23
Mean refractive error (diopter)
Sphere 22.91 22.72
Cylinder 20.48 20.48
Equivalent sphere 23.15 22.96
Mean visual acuity
log(1/Snellen fraction) 1.01 1.01
Table 3. Baseline Characteristics of Subjects Who Were
Randomly Assigned vs. Those Who Began Stage 2 Lens Wear
Adaptation but Failed to Proceed to Randomization. The
Similarities between Eligible Subjects from Whom Data Were
or Were Not Obtained Suggests that Statistical Inference from
our Stage 3 Results to the General Contact Lens Extended
Wear Study Population is Appropriate
Failed Stage 2
Adaptation
(n 5 344)
Randomly
Assigned
to Stage 3
(n 5 201)
Subjects with contact lens history (%) 23.26 20.40
Gender (%)
Male 58.14 56.22
Female 41.86 43.78
Ethnicity (%)
African American 7.56 5.97
Asian American 41.57 41.29
Caucasian 31.69 37.31
Hispanic American 10.47 7.46
Native American 0.29 1.00
Other 8.43 6.97
Mean age at orientation (years) 23.88 23.09
Mean corneal curvature (diopters)
Horizontal meridian 43.20 43.48
Vertical meridian 43.82 44.15
Toricity 0.75 0.77
Residual astigmatism 1.15 1.25
Mean refractive error (diopters)
Sphere 22.52 22.81
Cylinder 20.41 20.48
Equivalent sphere 22.73 23.06
Mean visual acuity
log(1/Snellen fraction) 0.97 1.01
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compared with the sample of 201 subjects who we randomly
assigned and for whom we collected follow-up data.
Conclusions
In this article we have described the purpose, design, and
conduct of the CLEWS clinical trial, the nature of the
hypoxic treatment, the protocols used to control bias and
ensure data integrity, and the baseline characteristics of the
CLEWS study population.
In summary, CLEWS was appropriately designed to
address the study hypotheses and was conducted with re-
gard for the safety of the subjects and the integrity of study
data. CLEWS adhered to rigorous protocols that were suc-
cessful in controlling for bias and maintaining balance in the
two study groups with respect to potential confounding
variables. Finally, we have provided the information on our
hypoxic treatment and the characteristics of our subjects
necessary for evaluating and interpreting the results that
follow in the companion article.
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